Sheryl M. Green

Sheryl M. Green

Auto-generated profile, based on publicly available information

Sheryl M. Green

Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2019 in Clinical Psychology & Psychotherapy
Verified
Journal Article
Closed access
PDF file
CGCorrie Goldfinger
Corrie Goldfinger
SGSheryl M. Green
Sheryl M. Green
MFMelissa Furtado
Melissa Furtado
RMRandi McCabe
Randi McCabe

14 December 2021 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
MFMelissa Furtado
Melissa Furtado
BFBenicio Frey
Benicio Frey
SGSheryl M. Green
Sheryl M. Green
Background: To date, there is a significant lack of research validating clinical tools for early and accurate detection of anxiety disorders in perinatal populations. Intolerance of uncertainty was recently identified as a significant risk factor for postpartum anxiety symptoms and is a key trait of non-perinatal anxiety disorders. The present study aimed to validate the Intolerance of Uncertainty Scale (IUS) in a perinatal population and evaluate its use as a screening tool for anxiety disorders. Methods: Psychiatric diagnoses were assessed in a sample of perinatal women (n = 198), in addition to completing a self-report battery of questionnaires. Psychometric properties including internal consistency and convergent and discriminant validity were assessed. Determination of an optimal clinical cut-off score was measured through a ROC analysis in which the area under the curve, sensitivity, specificity, as well as positive and negative predictive values were calculated. Results: The IUS demonstrated excellent internal consistency (α = 0.95) and an optimal clinical cut-off score of 64 or greater was established, yielding a sensitivity of 89%. The IUS also demonstrated very good positive (79%) and negative (80%) predictive values. Conclusions: These findings suggest that the IUS represents a clinically useful screening tool to be used as an aid for the early and accurate detection of perinatal anxiety.

1 August 2022 in Canadian Psychology / Psychologie canadienne
Verified
Journal Article
Closed access
AAArela Agako
Arela Agako
Pedro BallesterPedro Ballester
Pedro Ballester
VSVictoria Stead
Victoria Stead
RMRandi E. McCabe
Randi E. McCabe
SGSheryl M. Green
Sheryl M. Green

1 July 2021 in Behavior Therapy
Verified
Journal Article
Closed access
SGSheryl M. Green
Sheryl M. Green
EDEleanor Donegan
Eleanor Donegan
RMRandi E. McCabe
Randi E. McCabe
DSDavid L. Streiner
David L. Streiner
MFMelissa Furtado
Melissa Furtado
BFBenicio N. Frey
Benicio N. Frey

21 December 2021 in Clinical Psychology & Psychotherapy
Verified
Journal Article
Open access
PDF file
SGSheryl M. Green
Sheryl M. Green
MFMelissa Furtado
Melissa Furtado
BIBriar E. Inness
Briar E. Inness
BFBenicio Frey
Benicio Frey
RMRandi McCabe
Randi McCabe
The novel COVID pandemic has had a substantial impact on global mental health, including those populations that are inherently vulnerable such as pregnant and postpartum (perinatal) women. Anxiety disorders (ADs) are the most common mental health disorders during the perinatal period, affecting up to 1 in 5 women. However, since the onset of the pandemic, up to 60% of perinatal women are experiencing moderate to severe levels of anxiety. Given the substantial increase in perinatal anxiety during COVID, we sought to better understand its phenomenology by characterizing the collective worry content and impact of COVID using a content analysis. Eighty-four treatment-seeking pregnant (n = 35) and postpartum (n = 49) women with a principal AD, participated in this study between April and October 2020. In addition to completing questionnaire measures and a semi-structured diagnostic interview, participants were asked to 1) describe their top excessive and uncontrollable worries; 2) describe additional COVID and non-COVID worries; and 3) describe how the pandemic had affected their lives. All responses were given verbally and transcribed verbatim by assessors. A content analysis led to the emergence of various COVID and non-COVID worry and impact themes. One third of participant’s principal worries were specific to COVID, and 40% of COVID worries were specific to the perinatal context. Understanding the worry content and impact of COVID may improve symptom detection and inform the development of targeted treatment strategies to support the mental health needs of perinatal women with ADs throughout the pandemic and thereafter. Understanding pandemic-specific worries is important for perinatal symptom screening and may allow for the development of targeted treatment strategies to address COVID-specific worries and impact.

1 August 2023 in Psychological Services
Verified
Journal Article
Closed access
AAArela Agako
Arela Agako
LBLisa Burckell
Lisa Burckell
RMRandi McCabe
Randi McCabe
BFBenicio Frey
Benicio Frey
EBEmily Barrett
Emily Barrett
SGSheryl M. Green
Sheryl M. Green
The perinatal period (pregnancy and the first-year postpartum) is a time of increased vulnerability to mental health difficulties including emotion dysregulation. Research conducted on treatments targeting emotion dysregulation during this time is limited. Dialectical behavioral therapy (DBT) skills groups are considered the gold standard for targeting emotion dysregulation. We developed and evaluated the effectiveness of a seven-session DBT informed skills group (perinatal emotion regulation skills [Peri-ERS]) tailored to meet the unique emotion dysregulation experienced by women within the perinatal period. N = 41 perinatal women participated in the Peri-ERS group within the Women's Health Concern's Clinic, St. Joseph's Healthcare Hamilton. Participants completed a semistructured assessment to determine eligibility. They completed self-report symptom measures at baseline, Sessions 1-6, and posttreatment assessments. Paired-samples t tests, Cohen's d, and Friedman's rank tests were run to examine change over time. Reliable and clinical change index (RCI) analysis was conducted on emotion dysregulation. Participants demonstrated significant improvements in all symptom domain measures. Forty-eight percent of participants exhibited reliable clinical change on emotion dysregulation. These findings suggest the Peri-ERS group is effective in reducing emotion dysregulation symptoms for perinatal women. These results are promising as this novel treatment addresses a gap in the literature and may potentially be implemented in women's health clinics as a way of improving overall perinatal care. (PsycInfo Database Record (c) 2022 APA, all rights reserved).